Literature DB >> 15639124

Report of a Muscular Dystrophy Campaign funded workshop Birmingham, UK, January 16th 2004. Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention.

R Quinlivan1, H Roper, M Davie, N J Shaw, J McDonagh, K Bushby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15639124     DOI： 10.1016/j.nmd.2004.09.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  13 in total

1.  Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment.

Authors:  M L Bianchi; L Morandi; E Andreucci; S Vai; J Frasunkiewicz; R Cottafava
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Insights into bone health in Duchenne muscular dystrophy.

Authors:  Victor H Morgenroth; Lauren P Hache; Paula R Clemens
Journal:  Bonekey Rep       Date:  2012-02-01

3.  Use of bone age for evaluating bone density in patients with Duchenne muscular dystrophy: A preliminary report.

Authors:  Asma Al-Zougbi; Katherine D Mathews; Amal Shibli-Rahhal
Journal:  Muscle Nerve       Date:  2019-01-24       Impact factor: 3.217

Review 4.  Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.

Authors:  Jennifer M Bell; Michael D Shields; Janet Watters; Alistair Hamilton; Timothy Beringer; Mark Elliott; Rosaline Quinlivan; Sandya Tirupathi; Bronagh Blackwood
Journal:  Cochrane Database Syst Rev       Date:  2017-01-24

5.  Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study.

Authors:  Merel Jansen; Imelda Jm de Groot; Nens van Alfen; Alexander Ch Geurts
Journal:  BMC Pediatr       Date:  2010-08-06       Impact factor: 2.125

6.  The effects of muscular dystrophy on the craniofacial shape of Mus musculus.

Authors:  Donna Carlson Jones; Miriam L Zelditch; Paula Lightfoot Peake; Rebecca Z German
Journal:  J Anat       Date:  2007-04-25       Impact factor: 2.610

Review 7.  Bone health and associated metabolic complications in neuromuscular diseases.

Authors:  Nanette C Joyce; Lauren P Hache; Paula R Clemens
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-10-17       Impact factor: 1.784

8.  Fractures in children with Pompe disease: a potential long-term complication.

Authors:  Laura E Case; Rabi Hanna; Donald P Frush; Vidya Krishnamurthy; Stephanie DeArmey; Joanne Mackey; Anne Boney; Claire Morgan; Deyanira Corzo; Susan Bouchard; Thomas J Weber; Yuan-Tsong Chen; Priya S Kishnani
Journal:  Pediatr Radiol       Date:  2007-03-07

Review 9.  Drug treatment of Duchenne muscular dystrophy: available evidence and perspectives.

Authors:  Maria de los Angeles Beytía; Julia Vry; Janbernd Kirschner
Journal:  Acta Myol       Date:  2012-05

10.  The relationship of bone mineral density and vitamin D levels with steroid use and ambulation in patients with Duchenne muscular dystrophy.

Authors:  Filiz Meryem Sertpoyraz; Bedile İrem Tiftikçioğlu
Journal:  Turk J Phys Med Rehabil       Date:  2019-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.